Lupin arm unveils Luforbec 100/6 for adult asthma, COPD treatment in Germany Ruchika Sharma22 July 2023 2:30 PM ISTMumbai: Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, announced the launch of Luforbec 100/6 (beclometasone 100 µg / ...
Photon-counting CT may evaluate lung structure and function Dr. Kamal Kant Kohli21 July 2023 8:00 PM ISTNew CT technology allows for a comprehensive, simultaneous evaluation of lung structure and function, something not possible with standard CT,...
Echocardiography may predict Adverse Outcomes in COPD Patients Dr. Kamal Kant Kohli19 July 2023 8:00 PM ISTCardiovascular diseases often accompany chronic obstructive pulmonary disease (COPD), making their evaluation and management crucial in the overall...
Dupilumab lessens disease severity in COPD patients with type 2 inflammation Dr. Kamal Kant Kohli28 Jun 2023 8:00 PM ISTChronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the...
Lupin CSR arm, Maharashtra Govt collaborate to address growing prevalence of cardiovascular diseases, COPD Ruchika Sharma22 Jun 2023 1:30 PM ISTMumbai: Lupin Human Welfare and Research Foundation (LHWRF), the Corporate Social Responsibility (CSR) arm of Lupin Limited, has announced that it has...
Unveiling The Impact Of COPD On Individual Health And Its Management - Dr Mahavir Modi Dr Mahavir M Modi31 May 2023 11:51 AM ISTChronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung condition that impairs breathing and restricts airflow. It depicts the...
Lupin arm gets Health Canada nod to market generic version of Spiriva for COPD Ruchika Sharma27 May 2023 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that its Canada subsidiary, Lupin Pharma Canada Ltd., has received approval from Health...
Zolpidem use not linked with exacerbation or increased mortality in COPD patients Dr. Kamal Kant Kohli27 May 2023 9:00 AM ISTChronic obstructive pulmonary disease patients newly prescribed non-benzodiazepine benzodiazepine receptor agonists (NBZRAs) such as zolpidem (Ambien,...
New model may predict muscular calf vein thrombosis risk in acute COPD exacerbation Medha Baranwal21 April 2023 8:00 PM ISTChina: Researchers from China have developed a nomogram for predicting muscular calf vein thrombosis (MCVT) in patients with acute exacerbation of...
Zydus Lifesciences bags USFDA nod for pulmonary drug Roflumilast Ruchika Sharma20 April 2023 11:33 AM ISTThe drug will be manufactured at the group's formulation manufacturing facility in SEZ Ahmedabad, India.
Preterm babies at higher risk of having asthma or COPD in adulthood Dr. Kamal Kant Kohli18 April 2023 9:00 AM ISTNorway: A nationwide register study from Finland and Norway found that preterm babies are more likely to have chronic obstructive pulmonary disease...
Inhaled Triple Therapy including corticosteroids Reduces All-Cause Mortality in COPD Dr. Mahalakshmi Sivashankaran16 April 2023 8:00 PM ISTChina: A new study published in the Chest Journal found that inhaled therapy containing inhaled corticosteroids (ICSs) can reduce the risk of...
